<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We examined whether biomarkers of endothelial function, fibrinolysis/<z:mp ids='MP_0005048'>thrombosis</z:mp> and adiponectin, predict the progression from <z:mpath ids='MPATH_458'>normal</z:mpath> to pre-<z:mp ids='MP_0002055'>diabetes</z:mp> more strongly among women than men over 6 years of follow-up from the Western New York Health Study </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: In 2002-2004, 1,455 participants from the Western New York Health Study, who were free of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> at baseline (1996-2001), were selected for reexamination </plain></SENT>
<SENT sid="2" pm="."><plain>An incident case of pre-<z:mp ids='MP_0002055'>diabetes</z:mp> was defined as fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> &lt;100 mg/dl at the baseline examination and &gt; or =100 and &lt;126 mg/dl at the follow-up examination </plain></SENT>
<SENT sid="3" pm="."><plain>Biomarkers of endothelial function (E-selectin and soluble intracellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 [sICAM-1]), fibrinolysis/<z:mp ids='MP_0005048'>thrombosis</z:mp> (plasminogen activator inhibitor-1 [PAI-1]), and fasting insulin, adiponectin, and <z:mp ids='MP_0001845'>inflammation</z:mp> (high-sensitivity C-reactive protein) were measured in frozen (-190 degrees C) baseline samples </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Multivariate analyses revealed higher adjusted mean values of biomarkers of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> (E-selectin and sICAM-1) and fibrinolysis (PAI-1) and lower mean values of adiponectin only among women who developed pre-<z:mp ids='MP_0002055'>diabetes</z:mp> compared with control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>Formal tests for interaction between sex and case/control status were statistically significant for E-selectin (P = 0.042), PAI-1 (P = 0.001), sICAM-1 (P = 0.011), and frequency of <z:hpo ids='HP_0000822'>hypertension</z:hpo> (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: These results support the concept that women who progressed from normoglycemia to pre-<z:mp ids='MP_0002055'>diabetes</z:mp> have greater <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> than men as well as more <z:hpo ids='HP_0000822'>hypertension</z:hpo> and a greater degree of fibrinolysis/<z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Whether this relates to the higher risk of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> among diabetic women awaits further study </plain></SENT>
</text></document>